Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Microreactor Technology. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110845337B reveals a safer microreactor bromination route for kinase inhibitor intermediates, offering superior selectivity and scalable manufacturing solutions.
Novel microreactor process for MB-301 intermediates boosts yield to 90%. Reduces toxic ammonia use. Ideal for fluorescent tracer manufacturing.
Patent CN104356115B details microreactor synthesis for Avanafil intermediate ensuring high purity and supply chain stability for global pharmaceutical manufacturing partners.
Patent CN111848517B details a novel continuous flow method for Edaravone. Achieve high purity >99% and safer manufacturing. Contact us for supply.
Patent CN103588662A details a novel continuous-flow method for synthesizing Betamipron, offering enhanced purity and reduced toxicity for reliable pharmaceutical intermediate supply chains.
Patent CN103588662A details a continuous-flow microreactor method for synthesizing Betamipron, offering superior purity and cost reduction in API manufacturing compared to conventional batch processes.
Patent CN107056766B reveals high-purity Azilsartan synthesis via microreactor. Achieve significant cost reduction in API manufacturing and supply chain reliability.
Patent CN111056934A reveals a continuous flow method for alpha-hydroxyketone photoinitiators, offering superior purity, safety, and scalable manufacturing capabilities.
Patent CN111072515B reveals a green continuous flow method for cephalosporin intermediates, offering significant cost reduction and supply chain stability for global pharma manufacturers.